Disclosure
본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Business Philosophy
Pipeline
Pipeline
Q702
Q301
Telacebec (Q203)
Q901
5-Lipoxygenase Inhibitor
Clinical Trials
Clinical Trials
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
Company
Business Philosophy
Pipeline
Clinical Trials
IR / PR
Notice
Press Release
Stock Information
Financial
Disclosure
Disclosure
information for download file
* Name
Company
Phone
* Business e-mail
Comment
Request Download
팝업 닫기
Disclosure